{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:04:50Z","timestamp":1783911890959,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"New York Crohn's and Colitis Organization"},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK124570"],"award-info":[{"award-number":["K23DK124570"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10620-025-09652-1","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T11:16:10Z","timestamp":1767870970000},"page":"2394-2412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Longitudinal Study of Sexual Dysfunction in Men and Women with Inflammatory Bowel Disease Initiating Biologic or Small Molecule Therapy"],"prefix":"10.1007","volume":"71","author":[{"given":"Gabriel","family":"Castillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Beaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Delau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Lukin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Faye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Axelrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"9652_CR1","first-page":"92","volume":"20","author":"M Iglesias-Rey","year":"2014","unstructured":"Iglesias-Rey M, Acosta MB, Caama\u00f1o-Isorna F et al. Psychological Factors Are Associated with Changes in the Health-related Quality of Life in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2014;20:92\u2013102.","journal-title":"Inflammatory Bowel Diseases"},{"key":"9652_CR2","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1093\/ecco-jcc\/jjx100","volume":"11","author":"P Rivi\u00e8re","year":"2017","unstructured":"Rivi\u00e8re P, Zallot C, Desobry P et al. Frequency of and Factors Associated with sexual dysfunction in patients with inflammatory bowel disease. Journal of Crohn\u2019s and Colitis 2017;11:1347\u20131352.","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"9652_CR3","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/ecco-jcc\/jjv140","volume":"9","author":"G Mantzouranis","year":"2015","unstructured":"Mantzouranis G, Fafliora E, Glanztounis G et al. Inflammatory bowel disease and sexual function in male and female patients: an update on evidence in the past ten years. Journal of Crohn\u2019s Colitis 2015;9:1160\u20131168.","journal-title":"Journal of Crohn\u2019s Colitis"},{"key":"9652_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/ibd\/izx053","volume":"24","author":"A O\u2019Toole","year":"2018","unstructured":"O\u2019Toole A, de Silva PS, Marc LG et al. Sexual Dysfunction in men with inflammatory bowel disease: a new IBD-specific scale. Inflammatory Bowel Diseases 2018;24:310\u2013316.","journal-title":"Inflammatory Bowel Diseases"},{"key":"9652_CR5","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1093\/ibd\/izy202","volume":"24","author":"PS de Silva","year":"2018","unstructured":"de Silva PS, O\u2019Toole A, Marc LG et al. Development of a sexual dysfunction scale for women with inflammatory bowel disease. Inflammatory Bowel Diseases 2018;24:2350\u20132359.","journal-title":"Inflammatory Bowel Diseases"},{"key":"9652_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-230X-8-45","volume":"8","author":"A Timmer","year":"2008","unstructured":"Timmer A, Kemptner D, Bauer A et al. Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis. BMC Gastroenterology 2008;8:45.","journal-title":"BMC Gastroenterology"},{"key":"9652_CR7","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/ibd.20182","volume":"13","author":"A Timmer","year":"2007","unstructured":"Timmer A, Bauer A, Kemptner D et al. Determinants of male sexual function in inflammatory bowel disease: A survey-based cross-sectional analysis in 280 men. Inflammatory Bowel Diseases 2007;13:1236\u20131243.","journal-title":"Inflammatory Bowel Diseases"},{"key":"9652_CR8","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/ibd\/izy401","volume":"25","author":"E Shmidt","year":"2019","unstructured":"Shmidt E, Su\u00e1rez-Fari\u00f1as M, Mallette M et al. Erectile dysfunction is highly prevalent in men with newly diagnosed inflammatory bowel disease. Inflammatory Bowel Diseases 2019;25:1408\u20131416.","journal-title":"Inflammatory Bowel Diseases"},{"key":"9652_CR9","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/ibd\/izy397","volume":"25","author":"E Shmidt","year":"2019","unstructured":"Shmidt E, Su\u00e1rez-Fari\u00f1as M, Mallette M et al. A longitudinal study of sexual function in women with newly diagnosed inflammatory bowel disease. Inflammatory Bowel Diseases. 2019;25:1262\u20131270.","journal-title":"Inflammatory Bowel Diseases."},{"key":"9652_CR10","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1007\/s10620-018-5021-8","volume":"63","author":"S Eluri","year":"2018","unstructured":"Eluri S, Cross RK, Martin C et al. Inflammatory bowel diseases can adversely impact domains of sexual function such as satisfaction with sex life. Digestive Diseases and Sciences. 2018;63:1572\u20131582.","journal-title":"Digestive Diseases and Sciences."},{"key":"9652_CR11","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1111\/jsm.12966","volume":"12","author":"KP Weinfurt","year":"2015","unstructured":"Weinfurt KP, Lin L, Bruner DW et al. Development and initial validation of the PROMIS((R)) sexual function and satisfaction measures version 2.0. Journal of Sexual Medicine. 2015;12:1961\u20131974.","journal-title":"Journal of Sexual Medicine."},{"key":"9652_CR12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. Journal General Internal Medicine. 2001;16:606\u2013613.","journal-title":"Journal General Internal Medicine."},{"key":"9652_CR13","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1111\/j.1572-0241.2001.04682.x","volume":"96","author":"S Jowett","year":"2001","unstructured":"Jowett S, Seal CJ, Barton JR. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. The American Journal of Gastroenterology. 2001;96:2921\u20132928.","journal-title":"The American Journal of Gastroenterology."},{"key":"9652_CR14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/gutjnl-2015-310151","volume":"66","author":"C Gower-Rousseau","year":"2017","unstructured":"Gower-Rousseau C, Sarter H, Savoye G et al. Validation of the inflammatory bowel disease disability index in a population-based cohort. Gut. 2017;66:588\u2013596.","journal-title":"Gut."},{"key":"9652_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.cgh.2015.06.001","volume":"14","author":"L Peyrin-Biroulet","year":"2016","unstructured":"Peyrin-Biroulet L, Pan\u00e9s J, Sandborn WJ et al. Defining disease severity in inflammatory bowel diseases: current and future directions. Clinical Gastroenterol Hepatology. 2016;14:348-354.e17.","journal-title":"Clinical Gastroenterol Hepatology."},{"key":"9652_CR16","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/ibd\/izac204","volume":"29","author":"TC Mules","year":"2022","unstructured":"Mules TC, Swaminathan A, Hirschfeld E et al. The impact of disease activity on sexual and erectile dysfunction in patients with inflammatory bowel disease. Inflammatory Bowel Diseases. 2022;29:1244\u20131254.","journal-title":"Inflammatory Bowel Diseases."},{"key":"9652_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","volume":"1","author":"RF Harvey","year":"1980","unstructured":"Harvey RF, Bradshaw JM. A simple index of Crohn\u2019s-disease activity. The Lancet. 1980;1:514.","journal-title":"The Lancet."},{"key":"9652_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/gut.43.1.29","volume":"43","author":"RS Walmsley","year":"1998","unstructured":"Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998;43:29\u201332.","journal-title":"Gut."},{"key":"9652_CR19","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. N Engl J Med. 1987;317:1625\u20131629.","journal-title":"N Engl J Med."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09652-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09652-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09652-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T02:26:21Z","timestamp":1783909581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09652-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["9652"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09652-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jordan Axelrad: Research grants from BioFire Diagnostics, Genentech, Johnson & Johnson, and Takeda. Consultancy fees from AbbVie, Abviax, Adiso, Amgen, bioM\u00e9rieux, Bristol Myers Squibb, Celltrion, Eli Lilly, Ferring, Fresenius, Johnson & Johnson, Merck, Pfizer, Sanofi, Takeda, Vedanta. Dana Lukin: Consultancy fees from Abbvie, Altrubio, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Johnson & Johnson, Palatin Technologies, Pfizer, Prime Therapeutics, Prometheus Laboratories, PSI, Takeda, and Vedanta; has received speaker fees from Abbvie and Johnson & Johnson; and has received research\u00a0grants from Abbvie, Boehringer Ingelheim, Johnson & Johnson, and Takeda. Adam Faye: Consultancy fees from Eli Lilly and BMS; and\u00a0research grants from AbbVie and Takeda.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"IRB approval was obtained at each individual \u00a0institution. All subjects signed informed consent prior to enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}